Your browser doesn't support javascript.
loading
Exploring CRD mobility during RAS/RAF engagement at the membrane.
Nguyen, Kien; López, Cesar A; Neale, Chris; Van, Que N; Carpenter, Timothy S; Di Natale, Francesco; Travers, Timothy; Tran, Timothy H; Chan, Albert H; Bhatia, Harsh; Frank, Peter H; Tonelli, Marco; Zhang, Xiaohua; Gulten, Gulcin; Reddy, Tyler; Burns, Violetta; Oppelstrup, Tomas; Hengartner, Nick; Simanshu, Dhirendra K; Bremer, Peer-Timo; Chen, De; Glosli, James N; Shrestha, Rebika; Turbyville, Thomas; Streitz, Frederick H; Nissley, Dwight V; Ingólfsson, Helgi I; Stephen, Andrew G; Lightstone, Felice C; Gnanakaran, Sandrasegaram.
Afiliação
  • Nguyen K; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, New Mexico.
  • López CA; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, New Mexico.
  • Neale C; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, New Mexico.
  • Van QN; National Cancer Institute RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland.
  • Carpenter TS; Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, California.
  • Di Natale F; Applications, Simulations, and Quality, Lawrence Livermore National Laboratory, Livermore, California.
  • Travers T; Pebble Labs Inc., Los Alamos, New Mexico.
  • Tran TH; National Cancer Institute RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland.
  • Chan AH; National Cancer Institute RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland.
  • Bhatia H; Center for Applied Scientific Computing, Lawrence Livermore National Laboratory, Livermore, California.
  • Frank PH; National Cancer Institute RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland.
  • Tonelli M; National Magnetic Resonance Facility at Madison, Biochemistry Department, University of Wisconsin-Madison, Madison, Wisconsin.
  • Zhang X; Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, California.
  • Gulten G; National Cancer Institute RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland.
  • Reddy T; CCS-7, Los Alamos National Laboratory, Los Alamos, New Mexico.
  • Burns V; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, New Mexico.
  • Oppelstrup T; Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, California.
  • Hengartner N; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, New Mexico.
  • Simanshu DK; National Cancer Institute RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland.
  • Bremer PT; Center for Applied Scientific Computing, Lawrence Livermore National Laboratory, Livermore, California.
  • Chen; National Cancer Institute RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland.
  • Glosli JN; Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, California.
  • Shrestha R; National Cancer Institute RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland.
  • Turbyville T; National Cancer Institute RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland.
  • Streitz FH; Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, California.
  • Nissley DV; National Cancer Institute RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland.
  • Ingólfsson HI; Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, California.
  • Stephen AG; National Cancer Institute RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland.
  • Lightstone FC; Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, California.
  • Gnanakaran S; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, New Mexico. Electronic address: GNANA@lanl.gov.
Biophys J ; 121(19): 3630-3650, 2022 10 04.
Article em En | MEDLINE | ID: mdl-35778842
ABSTRACT
During the activation of mitogen-activated protein kinase (MAPK) signaling, the RAS-binding domain (RBD) and cysteine-rich domain (CRD) of RAF bind to active RAS at the plasma membrane. The orientation of RAS at the membrane may be critical for formation of the RAS-RBDCRD complex and subsequent signaling. To explore how RAS membrane orientation relates to the protein dynamics within the RAS-RBDCRD complex, we perform multiscale coarse-grained and all-atom molecular dynamics (MD) simulations of KRAS4b bound to the RBD and CRD domains of RAF-1, both in solution and anchored to a model plasma membrane. Solution MD simulations describe dynamic KRAS4b-CRD conformations, suggesting that the CRD has sufficient flexibility in this environment to substantially change its binding interface with KRAS4b. In contrast, when the ternary complex is anchored to the membrane, the mobility of the CRD relative to KRAS4b is restricted, resulting in fewer distinct KRAS4b-CRD conformations. These simulations implicate membrane orientations of the ternary complex that are consistent with NMR measurements. While a crystal structure-like conformation is observed in both solution and membrane simulations, a particular intermolecular rearrangement of the ternary complex is observed only when it is anchored to the membrane. This configuration emerges when the CRD hydrophobic loops are inserted into the membrane and helices α3-5 of KRAS4b are solvent exposed. This membrane-specific configuration is stabilized by KRAS4b-CRD contacts that are not observed in the crystal structure. These results suggest modulatory interplay between the CRD and plasma membrane that correlate with RAS/RAF complex structure and dynamics, and potentially influence subsequent steps in the activation of MAPK signaling.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas c-raf / Cisteína Idioma: En Revista: Biophys J Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas c-raf / Cisteína Idioma: En Revista: Biophys J Ano de publicação: 2022 Tipo de documento: Article